Literature DB >> 8922007

Subcutaneous lidocaine does not affect the success rate of intravenous access in children less than 24 months of age.

A D Sacchetti1, C Carraccio.   

Abstract

OBJECTIVE: To determine whether subcutaneous lidocaine (SQL), when used to decrease the pain of IV catheter insertion, adversely affects IV access in children < 24 months of age.
METHODS: A historically controlled comparison of IV access successes with and without SQL in children < 2 years of age was performed in a 30,000-annual-visit community hospital ED. On-site data collected at the time of IV placement included: patient age, weight, hydration status, number of attempts, and location of attempts. All patients had IV attempts made by the same emergency physician.
RESULTS: A total of 110 children, mean age 9.6 +/- 6.9 months, were included in the study analysis. Of the 110, 70 had an IV catheter placed with no pretreatment, while 40 had SQL pretreatment. The average number of attempts for all patients was 1.36 +/- 0.73, with 83 (75%) performed successfully in 1 attempt and 101 (91%) within 2 attempts. The mean numbers of attempts were similar for the control and SQL groups: 1.34 vs 1.40, respectively (p = 0.68), as were the proportions successful in 1 attempt (77% vs 73%; p = 0.58) and within 2 attempts (91% vs 90%; p = 0.84).
CONCLUSION: SQL use prior to an IV attempt in children < 2 years of age does not impact vascular access. A secondary finding was that vascular access with and without SQL in infants and small children generally can be accomplished in 1 attempt.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922007     DOI: 10.1111/j.1553-2712.1996.tb03345.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  1 in total

Review 1.  Pharmacological management of pain and anxiety during emergency procedures in children.

Authors:  R M Kennedy; J D Luhmann
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.